Congenital heart disease in aircrew

This article focuses i on the broad aviation medicine considerations that are required to optimally manage aircrew ii with suspected or confirmed congenital heart disease (both pilots and non-pilot aviation professionals). It presents expert consensus opinion and associated recommendations and is part of a series of expert consensus documents covering all aspects of aviation cardiology. This expert opinion was born out of a 3 year collaborative working group between international military aviation cardiologists and aviation medicine specialists, as part of a North Atlantic Treaty Organization (NATO) led initiative to address the occupational ramifications of cardiovascular disease in aircrew (HFM-251) many of whom also work with and advise civil aviation authorities.

[1]  E. Nicol,et al.  Management of established coronary artery disease in aircrew without myocardial infarction or revascularisation , 2018, Heart.

[2]  E. Nicol,et al.  Management of cardiac conduction abnormalities and arrhythmia in aircrew , 2018, Heart.

[3]  E. Nicol,et al.  Assessing aeromedical risk: a three-dimensional risk matrix approach , 2018, Heart.

[4]  E. Nicol,et al.  An introduction to aviation cardiology , 2018, Heart.

[5]  E. Nicol,et al.  Non-coronary cardiac surgery and percutaneous cardiology procedures in aircrew , 2018, Heart.

[6]  E. Nicol,et al.  Management of established coronary artery disease in aircrew with previous myocardial infarction or revascularisation , 2018, Heart.

[7]  J. Tobis,et al.  Cryptogenic Stroke and Patent Foramen Ovale. , 2018, Journal of the American College of Cardiology.

[8]  E. Verrier,et al.  Early outcomes in patients undergoing transcatheter versus surgical pulmonary valve replacement , 2017, Heart.

[9]  E. Nicol,et al.  CT Coronary Angiography vs. Coronary Artery Calcium Scoring for the Occupational Assessment of Military Aircrew. , 2017, Aerospace medicine and human performance.

[10]  D. McElhinney,et al.  Relative Risk Factors for Cardiac Erosion Following Transcatheter Closure of Atrial Septal Defects: A Case–Control Study , 2016, Circulation.

[11]  J. Carroll,et al.  Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. , 2013, The New England journal of medicine.

[12]  E. Nicol,et al.  Malignant anomalous left coronary artery associated with acute coronary syndrome and subsequent post-operative secondary stenosis of the reimplanted anomalous left coronary artery , 2012, Cardiology in the Young.

[13]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.

[14]  Helmut Baumgartner,et al.  ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). , 2010, European heart journal.

[15]  V. Thijs,et al.  NEW-ONSET AND PERSISTENT MIGRAINE EARLY AFTER PERCUTANEOUS ATRIAL SEPTAL DEFECT CLOSURE DISAPPEAR AT FOLLOW-UP , 2008, Acta clinica Belgica.

[16]  R. Abella,et al.  Transcatheter closure of perimembranous ventricular septal defects: early and long-term results. , 2007, Journal of the American College of Cardiology.

[17]  M. Rubens,et al.  Left main coronary atresia: A more commonly identified condition after the advent of 64-slice CT coronary angiography? , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[18]  M. Rubens,et al.  Assessment of adult congenital heart disease with multi-detector computed tomography: beyond coronary lumenography. , 2007, Clinical radiology.

[19]  Joon Beom Seo,et al.  Coronary artery anomalies: classification and ECG-gated multi-detector row CT findings with angiographic correlation. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.

[20]  J. Mašura,et al.  Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders. , 2005, Journal of the American College of Cardiology.

[21]  J. Elefteriades.  Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. , 2002, The Annals of thoracic surgery.

[22]  J. Hoffman,et al.  Task force 1: the changing profile of congenital heart disease in adult life. , 2001, Journal of the American College of Cardiology.

[23]  S. Siu,et al.  Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study , 2000, The Lancet.

[24]  H. Allen,et al.  Cardiovascular health and disease in children: current status. A Special Writing Group from the Task Force on Children and Youth, American Heart Association. , 1994, Circulation.

[25]  V. Fuster,et al.  Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. , 1993, The New England journal of medicine.

[26]  R. Hobbs,et al.  Coronary artery anomalies in 126,595 patients undergoing coronary arteriography. , 1990, Catheterization and cardiovascular diagnosis.